Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin

被引:104
|
作者
Espinel-Ingroff, A.
Arthington-Skaggs, B.
Iqbal, N.
Ellis, D.
Pfaller, M. A.
Messer, S.
Rinaldi, M.
Fothergill, A.
Gibbs, D. L.
Wang, A.
机构
[1] Virginia Commonwealth Univ, Med Ctr, Richmond, VA 23298 USA
[2] Ctr Dis Control, Atlanta, GA 30333 USA
[3] Womens & Childrens Hosp, Adelaide, SA, Australia
[4] Univ Iowa, Iowa City, IA USA
[5] Univ Texas San Antonio, San Antonio, TX 78285 USA
[6] Giles Sci Inc, Santa Barbara, CA USA
关键词
D O I
10.1128/JCM.00134-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The purpose of this study was to correlate inhibition zone diameters, in millimeters (agar diffusion disk method), with the broth dilution MICs or minimum effective concentrations (MECs) (CLSI M38-A method) of five antifungal agents to identify optimal testing guidelines for disk mold testing. The following disk diffusion testing parameters were evaluated for 555 isolates of the molds Absidia corymbifera,Aspergillus sp. (five species), Alternaria sp., Bipolaris spicifera, Fusarium sp. (three species), Mucor sp. (two species), Paecilomyces lilacinus, Rhizopus sp. (two species), and Scedosporium sp. (two species): (i) two media (supplemented Mueller-Hinton agar [2% dextrose and 0.5 mu g/ml methylene blue] and plain Mueller-Hinton [MH] agar), (ii) three incubation times (16 to 24, 48, and 72 h), and (iii) seven disks (amphotericin B and itraconazole 10-mu g disks, voriconazole 1- and 10-mu g disks, two sources of caspofungin 5-mu g disks [BBL and Oxoid], and posaconazole 5-mu g disks). MH agar supported better growth of all of the species tested (24 to 48 h). The reproducibility of zone diameters and their correlation with either MICs or MECs (caspofungin) were superior on MH agar (91 to 100% versus 82 to 100%; R, 0.71 to 0.93 versus 0.53 to 0.96 for four of the five agents). Based on these results, the optimal testing conditions for mold disk diffusion testing were (i) plain MH agar; (ii) incubation times of 16 to 24 h (zygomycetes), 24 h (Aspergillus fiumigatus, A. flavus, and A. niger), and 48 h (other species); and (iii) the posaconazole 5-mu g disk, voriconazole 1-mu g disk, itraconazole 10-mu g disk (for all except zygomycetes), BBL caspofungin 5-mu g disk, and amphotericin B 10-mu g (zygomycetes only).
引用
收藏
页码:1811 / 1820
页数:10
相关论文
共 50 条
  • [31] Hypha growth inhibition study for susceptibility testing of Aspergillus terreus to amphotericin B, voriconazole and itraconazole
    Teixeira-Loyola, A. B. A.
    Moretti, M. L.
    Trabasso, P.
    Kamei, K.
    Mikami, Y.
    Taguchi, H.
    Schreiber, A. Z.
    MYCOSES, 2012, 55 : 113 - 113
  • [32] Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole
    Ozkutuk, A.
    Ergon, C.
    Metin, D. Y.
    Yucesoy, M.
    Polat, S. H.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (01) : 87 - 92
  • [33] Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole
    Espinel-Ingroff, A
    Fothergill, A
    Ghannoum, M
    Manavathu, E
    Ostrosky-Zeichner, L
    Pfaller, M
    Rinaldi, M
    Schell, W
    Walsh, T
    JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (10) : 5243 - 5246
  • [34] Germinated and nongerminated conidial suspensions for testing of susceptibilities of Aspergillus spp. to amphotericin B, itraconazole, posaconazole, ravuconazole, and voriconazole
    Espinel-Ingroff, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) : 605 - 607
  • [35] Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species
    Arikan, S
    Lozano-Chiu, M
    Paetznick, V
    Nangia, S
    Rex, JH
    JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (12) : 3946 - 3951
  • [36] Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for In Vitro Susceptibility Testing of Itraconazole, Posaconazole, and Voriconazole against Madurella mycetomatis
    Nyuykonge, Bertrand
    van Amelsvoort, Lukas
    Eadie, Kimberly
    Fahal, Ahmed H.
    Verbon, Annelies
    van de Sande, Wendy
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (09)
  • [37] In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi:: The GISIA-2 study
    Morace, G.
    Drago, M.
    Scaltrito, M. M.
    Conti, S.
    Fanti, F.
    Polonelli, L.
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (05) : 508 - 513
  • [38] Effect of medium composition on static and cidal activity of amphotericin B, itraconazole, voriconazole, posaconazole and terbinafine against Aspergillus fumigatus:: A multicenter study
    Tortorano, AM
    Dannaoui, E
    Meletiadis, J
    Mallie, M
    Viviani, MA
    Piens, MA
    Rigoni, AL
    Bastide, JM
    Grillot, R
    JOURNAL OF CHEMOTHERAPY, 2002, 14 (03) : 246 - 252
  • [39] Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
    EspinelIngroff, A
    Bartlett, M
    Bowden, R
    Chin, NX
    Cooper, C
    Fothergill, A
    McGinnis, MR
    Menezes, P
    Messer, SA
    Nelson, PW
    Odds, FC
    Pasarell, L
    Peter, J
    Pfaller, MA
    Rex, JH
    Rinaldi, MG
    Shankland, GS
    Walsh, TJ
    Weitzman, I
    JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) : 139 - 143
  • [40] Comparative Evaluation of Disc Diffusion and E-test with Broth Micro-dilution in Susceptibility testing of Amphotericin B, Voriconazole and Caspofungin against Clinical Aspergillus isolates
    Gupta, Prashant
    Khare, Vineefa
    Kumar, Deepak
    Ahmaiy, Abrar
    Banerjee, Gopa
    Singh, Mastan
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (01) : DC4 - DC7